FOXP3 and neoplasm: To test these hypotheses, we transferred CD45.2 CD4+ GFP+ (Treg) or CD45.2 CD4+ GFP− CD62L+ (naïve T cells) from Foxp3-EGFP mice into CD45.1 tumor bearing mice (Figure 4c).